Counting the neurological cost of COVID-19

Document Type

Article

Department

Biological and Biomedical Sciences

Abstract

The neurological deficits caused by COVID-19, which were first reported in the early months of 2020, continue to intrigue neurologists and health-care professionals worldwide. As two new studies highlight, these manifestations are frequent and are expected to increase the burden of morbidity and mortality in the acute and chronic phases of COVID-19.

Comments

Volume, issue, and pagination are not provided by the author/publisher

Publication (Name of Journal)

Nature Reviews Neurology

Link to Full Text

Share

COinS